Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208478 · ClinicalTrials.gov registry record · NA
Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03208478: Completed NA study, sponsored by Stanford University.
NCT03208478 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03208478, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Nerve blocks are used to provide pain control after moderately painful orthopedic surgeries. Anterior Cruciate Ligament (ACL) reconstruction with patellar autograft is a painful orthopedic procedure performed after traumatic injury to the knee. Many patients undergoing ACL reconstruction receive a nerve block as part of their anesthetic care. These blocks can be performed in different locations along the femoral nerve, with advantages and disadvantages to each location. Recently published evidence indicates that there is no short-term difference in pain control between the two commonly-targeted locations ("Adductor Canal" and "Femoral"). However, studies involving patients undergoing total knee arthroplasty indicate that femoral blocks provide better pain control with movement than adductor canal blocks. As many patients undergoing ACL reconstruction use continuous passive motion (CPM) machines as part of rehabilitation starting on post-operative day one, the investigators hypothesize that pain control and quality of recovery in the first 48 hours after surgery will be superior with a continuous femoral block than with a continuous adductor canal block. The investigators plan to study this by randomizing patients presenting for ACL reconstruction to receive either a continuous femoral or continuous adductor canal block (both considered adequate means of pain control), and following them to 48 hours to determine the level of pain, quality of recovery score, opioid use, and CPM compliance.
Interventions
- PROCEDURE Adductor Canal perineural catheter placement
- PROCEDURE Femoral Nerve perineural catheter placement
- DEVICE Nimbus pump (Infutronix)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03208478
The ClinicalTrials.gov registry entry for NCT03208478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Adductor Canal perineural catheter placement is the first listed.
NCT03208478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03208478 about?
NCT03208478 is a clinical study titled "Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions". Nerve blocks are used to provide pain control after moderately painful orthopedic surgeries. Anterior Cruciate Ligament (ACL) reconstruction with patellar autograft is a painful orthopedic procedure performed after traumatic injury to the knee. Many patients undergoing ACL reconstruction receive a n...
What is the current status of trial NCT03208478?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-06-18. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT03208478?
The interventions under investigation include: Adductor Canal perineural catheter placement (PROCEDURE), Femoral Nerve perineural catheter placement (PROCEDURE), Nimbus pump (Infutronix) (DEVICE).
Who is sponsoring clinical trial NCT03208478?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.